Alphatec Holdings, Inc. (ATEC), through its wholly-owned subsidiaries, Alphatec Spine, Inc. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC's Organic Innovation Machine is focused on developing new approaches that integrate seamlessly with the SafeOp Neural InformatiX System to safely and reproducibly treat spine's various pathologies and achieve the goals of spine surgery. Alphatec's ultimate vision is to be the Standard Bearer in Spine.
Company profile
Ticker
ATEC
Exchange
Website
CEO
Patrick Miles
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
3M • Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • Teleflex • Resmed • Haemonetics • Hill-Rom • Nuvasive ...
SEC CIK
Corporate docs
Subsidiaries
Alphatec Spine, Inc. • EOS imaging S.A. ...
IRS number
202463898
ATEC stock data
Analyst ratings and price targets
Current price
Average target
$17.00
Low target
$14.00
High target
$20.00
Lake Street
Maintains
$20.00
Morgan Stanley
Maintains
$17.00
Needham
Maintains
$14.00
Latest filings (excl ownership)
8-K
ATEC Announces Select Preliminary Financial 2022 Results, 2023 Guidance
9 Jan 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
8-K
ATEC Reports Third Quarter 2022 Financial Results
3 Nov 22
8-K
ATEC Announces Select Preliminary Third Quarter 2022
11 Oct 22
8-K
Entry into a Material Definitive Agreement
3 Oct 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
8-K
ATEC Reports Second Quarter 2022 Financial Results
4 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
16 Jun 22
8-K
Regulation FD Disclosure
25 May 22
SD
Conflict minerals disclosure
17 May 22
Transcripts
ATEC
Earnings call transcript
2022 Q3
6 Nov 22
ATEC
Earnings call transcript
2022 Q2
6 Aug 22
ATEC
Earnings call transcript
2022 Q1
8 May 22
ATEC
Earnings call transcript
2021 Q4
2 Mar 22
ATEC
Earnings call transcript
2021 Q3
7 Nov 21
ATEC
Earnings call transcript
2021 Q2
4 Aug 21
ATEC
Earnings call transcript
2021 Q1
8 May 21
ATEC
Earnings call transcript
2020 Q4
5 Mar 21
ATEC
Earnings call transcript
2020 Q3
7 Nov 20
ATEC
Earnings call transcript
2020 Q2
9 Aug 20
Latest ownership filings
Financial summary
| Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 106.11 mm | 106.11 mm | 106.11 mm | 106.11 mm | 106.11 mm | 106.11 mm |
| Cash burn (monthly) | 452.67 k | 9.81 mm | 12.29 mm | 13.07 mm | 4.90 mm | 6.80 mm |
| Cash used (since last report) | 1.82 mm | 39.48 mm | 49.44 mm | 52.59 mm | 19.70 mm | 27.35 mm |
| Cash remaining | 104.29 mm | 66.64 mm | 56.67 mm | 53.52 mm | 86.41 mm | 78.76 mm |
| Runway (months of cash) | 230.4 | 6.8 | 4.6 | 4.1 | 17.6 | 11.6 |
Institutional ownership, Q3 2022
71.7% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 158 |
| Opened positions | 23 |
| Closed positions | 23 |
| Increased positions | 60 |
| Reduced positions | 40 |
| 13F shares | Current |
|---|---|
| Total value | 679.94 mm |
| Total shares | 75.36 mm |
| Total puts | 14.90 k |
| Total calls | 45.00 k |
| Total put/call ratio | 0.3 |
| Largest owners | Shares | Value |
|---|---|---|
| L-5 Healthcare Partners | 14.59 mm | $105.04 mm |
| Squadron Capital | 11.54 mm | $144.53 mm |
| BLK Blackrock | 4.94 mm | $43.21 mm |
| Vanguard | 3.50 mm | $30.61 mm |
| First Light Asset Management | 2.97 mm | $26.00 mm |
| Deerfield Management | 2.53 mm | $22.14 mm |
| Armistice Capital | 2.44 mm | $21.29 mm |
| JHG Janus Henderson | 1.94 mm | $16.92 mm |
| Next Century Growth Investors | 1.92 mm | $16.75 mm |
| Avidity Partners Management | 1.72 mm | $14.99 mm |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 25 Jan 23 | L-5 Healthcare Partners | Common Stock | Payment of exercise | Dispose F | No | No | 13.14 | 532,513 | 7.00 mm | 10,997,833 |
| 25 Jan 23 | L-5 Healthcare Partners | Common Stock | Option exercise | Acquire M | No | No | 3.5 | 2,000,000 | 7.00 mm | 11,530,346 |
| 25 Jan 23 | L-5 Healthcare Partners | Warrants to Purchase Common Stock Common Stock | Dispose X | No | No | 3.5 | 2,000,000 | 7.00 mm | 2,346,032 | |
| 24 Jan 23 | Miles Patrick | Common Stock | Sell | Dispose S | No | Yes | 13.18 | 60,000 | 790.80 k | 5,301,633 |
| 23 Jan 23 | Miles Patrick | Common Stock | Sell | Dispose S | No | Yes | 13.17 | 60,000 | 790.20 k | 5,361,633 |
| 20 Jan 23 | Miles Patrick | Common Stock | Sell | Dispose S | No | Yes | 13.12 | 60,000 | 787.20 k | 5,421,633 |
| 19 Jan 23 | Miles Patrick | Common Stock | Sell | Dispose S | No | Yes | 13.33 | 60,000 | 799.80 k | 5,481,633 |
| 18 Jan 23 | Miles Patrick | Common Stock | Sell | Dispose S | No | Yes | 13.3 | 60,000 | 798.00 k | 5,541,633 |
| 17 Jan 23 | Miles Patrick | Common Stock | Sell | Dispose S | No | Yes | 13.05 | 60,000 | 783.00 k | 5,601,633 |
| 9 Jan 23 | David Sponsel | Common Stock | Sell | Dispose S | No | Yes | 11.99 | 10,000 | 119.90 k | 546,983 |
News
Lake Street Maintains Buy on Alphatec Holdings, Raises Price Target to $20
12 Jan 23
Morgan Stanley Maintains Overweight on Alphatec Holdings, Raises Price Target to $17
6 Jan 23
Alphatec Holdings's Return On Capital Employed Overview
21 Nov 22
Analyst Ratings for Alphatec Holdings
4 Nov 22
Needham Maintains Buy on Alphatec Holdings, Raises Price Target to $14
4 Nov 22